COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.

Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 1

Debería usarse Ketamina para el tratamiento de la agitación/delirio en el ámbito pre-hospitalario /emergencias?

Red Argentina Pública de ETS.

DESCRIPCIÓN DE LA TECNOLOGÍA Y TECNOLOGÍAS ALTERNATIVAS: La ketamina se ha utilizado durante más de 50 años para la inducción y el mantenimiento de la anestesia. Tiene propiedades únicas, incluida la capacidad de producir analgesia profunda y amnesia mientras se mantienen reflejos de las vías re...

Emergence Delirium/drug therapy, Ketamine/therapeutic use, Technology Assessment, Biomedical, Cost Efficiency Analysis

Fulltext